Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 21.0
(1.4%)
CNY 21.0
(1.4%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 246.35 Million CNY | 93.99% |
| 2022 | 126.99 Million CNY | 60.65% |
| 2021 | 79.05 Million CNY | -45.45% |
| 2020 | 144.9 Million CNY | -7.87% |
| 2019 | 157.27 Million CNY | 45.5% |
| 2018 | 108.09 Million CNY | -42.92% |
| 2017 | 189.37 Million CNY | -29.64% |
| 2016 | 269.14 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 335.02 Million CNY | 3.1% |
| 2024 Q3 | 306.3 Million CNY | -8.57% |
| 2024 Q1 | 324.93 Million CNY | 31.9% |
| 2023 Q3 | 198.44 Million CNY | 3.23% |
| 2023 Q2 | 192.23 Million CNY | 22.23% |
| 2023 Q1 | 157.27 Million CNY | 23.85% |
| 2023 FY | 246.35 Million CNY | 93.99% |
| 2023 Q4 | 246.35 Million CNY | 24.14% |
| 2022 Q4 | 126.99 Million CNY | 41.45% |
| 2022 Q3 | 89.78 Million CNY | -6.96% |
| 2022 Q2 | 96.5 Million CNY | -0.15% |
| 2022 Q1 | 96.64 Million CNY | 22.26% |
| 2022 FY | 126.99 Million CNY | 60.65% |
| 2021 Q2 | 117.38 Million CNY | -12.92% |
| 2021 FY | 79.05 Million CNY | -45.45% |
| 2021 Q1 | 134.78 Million CNY | -6.98% |
| 2021 Q4 | 79.05 Million CNY | -10.9% |
| 2021 Q3 | 88.72 Million CNY | -24.42% |
| 2020 Q4 | 144.9 Million CNY | 0.0% |
| 2020 FY | 144.9 Million CNY | -7.87% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | 190.04 Million CNY | 0.0% |
| 2019 Q2 | 111.76 Million CNY | 13.1% |
| 2019 Q4 | 157.27 Million CNY | 8.29% |
| 2019 Q3 | 145.23 Million CNY | 29.95% |
| 2019 FY | 157.27 Million CNY | 45.5% |
| 2019 Q1 | 98.81 Million CNY | 0.0% |
| 2018 FY | 108.09 Million CNY | -42.92% |
| 2017 FY | 189.37 Million CNY | -29.64% |
| 2016 FY | 269.14 Million CNY | 0.0% |